A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and ...
Higher vaccine efficacy was observed with mRNA-1283 vs mRNA-1273.222 in individuals aged 65 years and older. A phase 3 trial evaluating Moderna’s next-generation COVID-19 vaccine, mRNA-1283, met its ...
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results